skin of color
Latest Breakthroughs in Vascular Anomalies
Dr. Erin Mathes shared updates in the evaluation and treatment of vascular anomalies, including infantile hemangioma (IH) and port wine birthmarks (PWB). First, Mathes reviewed the clinical practice guidelines for managing IH. High-risk patients should be referred to a hemangioma specialist. The optimal referral age is 4 weeks. Mathes suggested that clinicians adjust their treatment…
Melanonychia and the Study of Nail Diseases
For 35 years, Judith Domínguez-Cherit, MD, has worked as a dermatologist and assistant professor of dermatology at the Dr. Manuel Gea González General Hospital, the same practice her father, the distinguished dermatologist Luciano Domínguez-Soto, started in 1977. “When I was young, my father took me with him to the hospital,” she said. “I became interested…
How I Do It: Psoriasis in Skin of Color
Dr. Ginette Okoye presented information about the clinical presentation and treatment of psoriasis in patients with skin of color. First, Dr. Okoye described the clinical presentation of psoriasis in patients with skin of color. Classic psoriasis, characterized by well-demarcated erythematous (red) plaques and micaceous (silver-colored) scales, can occur in these patients. Non-classic presentations of psoriasis…
Common and Uncommon Pitfalls in Clinicopathologic Correlation
Dr. Olayemi Sokumbi discussed three patient cases that demonstrate pitfalls in clinicopathologic correlation (CPC), the correlation between clinical and histopathological diagnosis. She believes that the gold standard for diagnosis involves collaboration between the dermatologist and dermatopathologist. Case #1: Double whammy A 28-year-old male presented with scattered plaques and nodules on his arms and legs. He…
The Melanoma Epidemic: Real or Illusory
In 2023, the United States Preventive Services Task Force determined there was insufficient evidence to assess the balance of benefits and harms of screening for melanoma using a whole-body skin examination in the primary care setting in part due to the lack of randomized controlled studies. Such studies addressing the mortality benefit of screening for skin cancer would be a massive undertaking. On a practical level, there are not enough dermatologists in the country to screen all American adults for skin cancer.
Serving the Underserved, Encouraging the Underrepresented
Hidradenitis suppurativa (HS) was a skin disease Dr. Ginette Okoye had never given much thought to before she entered her first faculty appointment.